Hjem › Tripelnegativ brystkreft › District of Columbia
Kliniske studier for Tripelnegativ brystkreft i District of Columbia
7 studier for Tripelnegativ brystkreft søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Washington Hospital Center ( Site 0098), Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06841354Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Georgetown University Medical Center, Washington D.C.
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05983432Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT05633654A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Washington D.C.
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07182149Study of XB010 in Subjects With Solid Tumors
- Georgetown University Medical Center, Washington D.C.
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jun. 2026 · NCT06545331I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Georgetown University Medical Center, Washington D.C.
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT01042379CtDNA Based MRD Testing for NAC Monitoring in TNBC
- George Washington University, Washington D.C.
RekruttererObservasjonsstudie
Alder 18 og eldre · Kvinner · Oppdatert 7. jan. 2025 · NCT06230185Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.